Pilar Giraldo – Medical field – Lifetime achievement Award

Published on by Network Science

Pilar Giraldo – Medical field – Lifetime achievement Award

Dr. Pilar Giraldo distinguished academic and researcher in the field Identification of patient-reported outcome measures and patient-reported experience measures in Gaucher disease in Spain. Dr. Pilar Giraldo Castellano appears highly suitable for the Research for Lifetime Achievement Award based on her extensive contributions and accomplishments in the field of hematology, particularly focusing on rare diseases.

🌐 Professional Profile

Educations📚📚📚

  • PhD in Medicine and accredited as a Full Professor by ANECA.
  • Master’s in Research Methodology and Molecular Oncology.
  • Coordinator of Doctorate studies at University San Jorge.

  • Research and Publications:

    • Head of research group Unit 752 of the Center for Biomedical Research Network on Rare Diseases (CIBERER).
    • Published over 140 articles in peer-reviewed journals, more than 20 book chapters, and 5 monographs.
    • Holds 5 patents related to her field.

  • Leadership in Research Projects:

    • Principal Investigator in numerous significant projects, such as the National Plan project TED2021-131518B-C32.
    • Directed more than 20 doctoral theses.
    • Led various research initiatives focusing on lysosomal diseases and other hematological conditions.

  • International Recognition and Collaboration:

    • Organized national and international congresses, including the 12th EWGGD Congress in 2016.
    • Part of the Expert Committee of the IWGGD and the Task Force on GD of the EHA.
    • Collaborates extensively with international bodies and foundations.

  • Awards and Recognition:

    • Received multiple awards for her contributions and those of her research group members at national and international congresses.
    • Recognized for her innovative work in utilizing artificial intelligence and machine learning in medical research.

  • Teaching and Mentorship:

    • Directed numerous continuing education courses for physicians.

Created educational resources and has been involved in life-long learning activities.

📝🔬Publications📝🔬

  • Elstein D, Belmatoug N, Bembi B, Deegan P, Fernandez-Sasso D, Giraldo P,
    Göker-Alpan Ö, Hughes D, Lau H, Lukina E, Revel-Vilk S, Schwartz IVD, Istaiti M, Botha J,
    Gadir N, Schenk J, Zimran A; GOS Study Group. 2024. Twelve Years of the Gaucher
    Outcomes Survey (GOS): Insights, Achievements, and Lessons Learned from a Global
    Patient Registry.J Clin Med.13-12.
  • Wallace EL, Goker-Alpan O, Wilcox WR, Holida M, Bernat J, Longo N, Linhart
    A, Hughes DA, Hopkin RJ, Tøndel C, Langeveld M, Giraldo P, Pisani A, Germain DP, Mehta
    A, Deegan PB, Molnar MJ, Ortiz D, Jovanovic A, Muriello M, Barshop BA, Kimonis V,
    Vujkovac B, Nowak A, Geberhiwot T, Kantola I, Knoll J, Waldek S, Nedd K, Karaa A, BrillAlmon E, Alon S, Chertkoff R, Rocco R, Sakov A, Warnock DG.;. 2024. Head-to-head trial
    of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and
    deteriorating renal function: results from the 2-year randomised phase III BALANCE
    study. J Med Genet.21-61, pp.520-530.
  • Serrano-Gonzalo I, de Frutos LL, Lahoz-Gil C, Delgado-Mateos F, FernándezGalán MÁ, Morales-Conejo M, Calle-Gordo MV, Ibarretxe-Gerediaga D, MadinaveitiaOchoa A, Albarracin-Arraigosa A, Balanzat-Muñoz J, Correcher-Medina P, García-Frade LJ,
    Hernández-Rivas JM, Labbadia F, López-Dupla JM, Lozano-Almela ML, Mora-Casterá E,
    Noya-Pereira MS, Ruíz-Guinaldo MÁ, Del Mar Tormo-Díaz M, Vitoria-Miñana I, ArévaloVargas I, Andrade-Campos M, Giraldo P. Real life data: follow-up assessment on Spanish
    3
    Gaucher disease patients treated with eliglustat. TRAZELGA project.. 2023. Real life data:
    follow-up assessment on Spanish Gaucher disease patients treated with eliglustat.
    TRAZELGA project. Orphanet J Rare Dis.18-1.
  • Stanescu S, Correcher Medina P, Del Castillo FJ, Alonso Luengo O, Arto
    Millan LM, Belanger Quintana A, Camprodon Gomez M, Diez Langhetée L, Garcia Campos
    O, Matas Garcia A, Perez-Moreno J, Rubio Gribble B, Visa-Reñé N, Giraldo-Castellano P,
    O’Callaghan Gordo M. 2023. Clinical Outcomes of Patients with Chronic Neuropathic
    Form of Gaucher Disease in the Spanish Real-World Setting: A Retrospective
    Study.Biomedicines.11-10.
  • Linhart A, Dostálová G, Nicholls K, West ML, Tøndel C, Jovanovic A, Giraldo P,
    Vujkovac B, Geberhiwot T, Brill-Almon E, Alon S, Chertkoff R, Rocco R, Hughes. 2023.
    Safety and efficacy of pegunigalsidase alfa in patients with Fabry disease who were
    previously treated with agalsidase alfa: results from BRIDGE, a phase 3 open-label study.
    Orphanet J Rare Dis. 18-1, pp.332.
  • Louw VJ, Fraser I, Giraldo P 2023. Management goals of type 1 Gaucher
    disease in South Africa: An expert Delphi consensus document on good clinical
    practice.PLoS One. 18-8.
  • Esther Valero Tena; Mercedes Roca Espiau; Jose Verdu Diaz; Jordi Diaz
    Manera; Marcio Andrade Campos; Pilar Giraldo Castellano. 2023. Advantages of digital
    technology in the assessment of bone marrow involvement in Gaucher’s disease. Front Med
    (Lausanne).

Panagiotis Karanis – Biomedical Research – Best Researcher Award

Published on by Network Science

Panagiotis Karanis – Biomedical Research

Dr. Panagiotis karanis  distinguished academic and researcher in the field Biomedical research, infectious diseases, climate changes.  Professor Karanis is a resourceful and dedicated professor with an impressive academic background,
excellent publication record and significant teaching experiences in the fields of Emerging Infectious
Parasitic and Tropical Diseases and Human Anatomy. Possesses excellent interpersonal and liaison skills
with the ability to build and maintain positive working relationships. Possesses mature administrative and
managerial skills and solid experience in science policy and public health. Enjoys worldwide collaborating
in a productive and successful team and thrives in challenging environments. He was 1000 Talent Plan
Expert (2014-2017) in Qinghai, China.

🌐 Professional Profiles

Educations: 📚🎓

Professor Dr. Panagiotis Karanis has held various esteemed positions in the field of anatomy and biomedicine, showcasing an extensive and distinguished career spanning several decades. From 2019 to the present, he serves as a Professor of Anatomy and the Coordinator of the Unit of Anatomy & Morphology at the Medical School, University of Nicosia, Nicosia, Cyprus. His contributions extend globally, as he has been an international advisor, consultant, and visiting professor at numerous universities.

During the period from 2014 to 2018, Professor Karanis held the position of Professor and Director of the Centre of Biomedicine and Infectious Diseases at the State Key Laboratory for Plateau Ecology and Agriculture at Qinghai University in Xining, China. His expertise was recognized internationally, as he was selected as a Foreign Expert in the 1000 Talent Plan, Recruitment Program of Foreign Experts (RPFE) for non-ethnic Chinese experts in China.

Earlier in his career, from 2009 to the present, Professor Karanis made significant contributions as a Professor of Anatomy at the Medical School, University of Cologne, Germany. Prior to this, he served as an Associate Professor and later as a Full Professor at the National Research Centre for Protozoan Diseases (NRCPD) in Japan from 2006 to 2007.

The trajectory of Professor Karanis’s career is marked by academic achievements. In 1999, he received Venia legendi in Parasitology (PD Dr.) and completed his Habilitation in Clinical-Theoretical Medicine at the Medical Faculty, University of Bonn, Germany. His academic journey began with a PhD in Parasitology, focusing on ‘UV-Disinfection of Protozoan Parasites’ at the University of Bonn in 1992. Earlier, in 1987, he earned a Diploma in Biology from the University of Bochum, Germany.

Professor Karanis’s educational background is diverse, including studies in Biology at the Universities of Bielefeld, Düsseldorf, and Bochum from 1980 to 1986. He also pursued complementary studies of Medicine at the Universities of Bochum and Cologne, completing the pre-clinical medical curriculum. His commitment to academia and research has made him a respected figure in the international scientific community, contributing significantly to the fields of anatomy, biomedicine, and parasitology.

Research Interests: 🧬🔬

Biomedical research, infectious diseases, climate changes,Applications of Network Science and Graph Analytics in Social, Biological, and Technological Networks

Awards and Achievements: 🏆👏

  •  Prof. Karanis is included on the annual list of 100,000 top scientists worldwide and, correspondingly, in
    the top 2 per cent of scientists in their field, according to a team of researchers at Stanford University in
    the USA. The updated 2020 list is based on a range of citation metrics that provides standardized data
    across those fields and subfields, in arriving at the (2019) single year impact result of more than 8,000,000
    scientists worldwide.
  • Gained worldwide administrative and managerial skills and experiences in science policy and public
    health. Successfully established 5 Laboratories / Institutions in Bonn / Germany (Waterborne and Vectorborne
    Parasitic Diseases), Thessaloniki / Greece (Leishmania and Sandflies), Cologne / Germany (Medical and
    Molecular Parasitology), Obihiro / Japan (Unit for Diseases Control and Genetics), Xining / China (Centre
    of Biomedicine and Infectious Diseases; the laboratory was promoted from the Chinese Government toState Key Laboratory of the Qinghai Province in China, 2016). The laboratories in Germany, Japan and
    China achieved an international reputation
  • Developed worldwide effective cooperations between many countries, in particular betweenEuropean
    and Asian countries
  •  Consultant at Qatar National Research Foundation and Qatar University, Doha, Qatar
  • Academic program review for the Master of Science in Biomedical Science, College of Health
    Sciences at Qatar University, Doha, Qatar, September 2018
  • Consultant” at Walailak University, Nakhon Si Thammarat, Thailand
  • Nominated as “Advisory Board Member” of the “Centre of Excellence for Medical Research and
    Innovative Products (CEMRIP)” in Thailand.
  • Nominated “National Distinguished Expert” and “State Specially Recruited Expert” of China
  • Selected in 1000 Talent Plan, the Recruitment Program of Foreign Experts (RPFE) for non-ethnic Chinese
    experts, China, 2014, leading into ongoing innovative and promising collaborations with China
  • Invitation for Short Term – Fellowship – Program for Malaria Research in Japan by JSPS (Japanese
    Society of Promotion of Science), 12th January – 11th March 2014

Career Summary 

Dr. Panagiotis Karanis is a distinguished parasitologist with a wealth of expertise and a prolific career spanning several prestigious institutions across the globe. Serving as a Guest Professor at the University of Padova in Italy during 2019 and 2020, as well as a Consultant at the College of Public Health in Qatar in 2018, he contributed significantly to the field of parasitology. Dr. Karanis has been a Consultant at Walailak University in Thailand since 2017, where he has provided guidance and international supervision for PhD students.

His academic endeavors include roles as an Invited Professor at the University of Alexandroupolis and the University of Ioannina in Greece, where he delivered lectures on infectious diseases to both undergraduate and postgraduate students. Notably, from 2014 to 2018, Dr. Karanis held the position of Professor and Director of the Centre of Biomedicine and Infectious Diseases at Qinghai University in China.

As a Foreign Expert in the 1000 Talent Plan Recruitment Program, he played a pivotal role in elevating the laboratory to the State Key Laboratory for Plateau Ecology and Agriculture of the Qinghai Province. Dr. Karanis’s contributions extended to advising the Chinese government on research ideas, particularly in waterborne and vectorborne diseases, and his efforts in developing Cryptosporidium culture assays for drug testing garnered recognition and funding from prestigious institutions such as the Bill and Melinda Gates Foundation. His comprehensive involvement in academia, research, and international collaborations underscores his commitment to advancing the field of parasitology and infectious diseases.

 

📚Top Noted Publication